Clinical Trial Update: A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers [Phase 2]

View source ↗

Summary

Phase II trial of XmAb20717 for advanced rare cancers has been suspended, with eligibility including microsatellite instability-high cancers and a range of extr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Carcinoma
• Hodgkin Lymphoma
• Microsatellite Instability-high Cancers
• Neuroendocrine Carcinoma
• Peritoneal Mesothelioma
• Pleural Mesothelioma
• Small Cell Lung Cancer

Drugs mentioned

• XmAb20717

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Microsatellite High Cancers, Peritoneal Mesothelioma | Phase 2 | Status: SUSPENDED